ANIP

Dopo l'orario di chiusura: 74.21

Ani Pharmaceuticals Inc (ANIP)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione Frazionamento azionario

Precedente Chiudi:

Volume 24 ore:

Relative Volume:

Capitalizzazione di mercato:

Utile/perdita netta:

Rapporto P/E:

Flusso di cassa netto:

1 W Prestazione:

1M Prestazione:

6M Prestazione:

1 anno Prestazione:

Intervallo 1D:

Intervallo di 1 settimana:

Portata 52W:

Ani Pharmaceuticals Inc Stock (ANIP) Company Profile

Ani Pharmaceuticals Inc

Healthcare (1118)

(218) 634-3500

210 MAIN STREET WEST, BAUDETTE, MN

Prossima data di guadagno

Ultimi documenti SEC

ANIP's Discussions on Twitter

Compare ANIP vs TAK, ZTS, HLN, TEVA, UTHR

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
ANIP Ani Pharmaceuticals Inc	74.21	1.66B	883.37M	71.37M	150.90M	3.3516
TAK Takeda Pharmaceutical Co Adr	18.74	59.20B	29.85B	776.90M	4.35B	0.2408
ZTS Zoetis Inc	117.94	49.79B	9.47B	2.67B	2.28B	6.0218
HLN Haleon Plc Adr	9.93	44.27B	14.54B	2.22B	2.58B	0.4871
TEVA Teva Pharmaceutical Industries Ltd Adr	30.08	35.03B	17.41B	1.43B	1.00B	1.2182
UTHR United Therapeutics Corp	564.81	24.75B	3.18B	1.33B	1.04B	27.90

Ani Pharmaceuticals Inc Stock (ANIP) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2025-07-10	Iniziato	H.C. Wainwright	Buy
2025-03-14	Iniziato	Jefferies	Buy
2025-03-12	Iniziato	JP Morgan	Overweight
2024-12-11	Iniziato	Leerink Partners	Outperform
2024-10-11	Iniziato	Piper Sandler	Overweight
2024-03-15	Iniziato	CapitalOne	Overweight
2023-08-22	Reiterato	H.C. Wainwright	Buy
2023-03-01	Iniziato	Guggenheim	Buy
2022-09-07	Iniziato	H.C. Wainwright	Buy
2021-11-02	Iniziato	Truist	Buy
2020-05-07	Downgrade	Cantor Fitzgerald	Overweight → Neutral
2019-09-12	Iniziato	Guggenheim	Buy
2019-05-10	Downgrade	Raymond James	Strong Buy → Outperform
2017-10-16	Reiterato	Canaccord Genuity	Buy
2017-07-31	Iniziato	Canaccord Genuity	Buy
2017-02-22	Downgrade	ROTH Capital	Buy → Neutral
2016-06-23	Iniziato	Raymond James	Strong Buy
2016-05-24	Downgrade	Standpoint Research	Buy → Hold
2015-11-13	Iniziato	Standpoint Research	Buy
2015-09-28	Aggiornamento	ROTH Capital	Neutral → Buy
2015-08-05	Reiterato	Oppenheimer	Outperform
2015-08-04	Reiterato	ROTH Capital	Neutral
2015-07-31	Reiterato	Oppenheimer	Outperform
2015-07-15	Reiterato	ROTH Capital	Neutral
2015-06-23	Reiterato	Oppenheimer	Outperform
2015-05-18	Reiterato	ROTH Capital	Neutral
2015-05-06	Reiterato	Oppenheimer	Outperform
2015-04-10	Downgrade	ROTH Capital	Buy → Neutral
2015-02-26	Reiterato	ROTH Capital	Buy
2015-02-18	Reiterato	Oppenheimer	Outperform

Mostra tutto

Ani Pharmaceuticals Inc Borsa (ANIP) Ultime notizie

Ani Pharmaceuticals Inc Azioni (ANIP) Dati Finanziari

Ani Pharmaceuticals Inc (ANIP)

Ani Pharmaceuticals Inc Stock (ANIP) Company Profile

Compare ANIP vs TAK, ZTS, HLN, TEVA, UTHR

Ani Pharmaceuticals Inc Stock (ANIP) Upgrades & Downgrades

Ani Pharmaceuticals Inc Borsa (ANIP) Ultime notizie

Travel Stocks: Will ANI Pharmaceuticals Inc stock go up in YEAR2026 Big Picture & Real-Time Stock Entry Alerts - baoquankhu1.vn

ANI Pharmaceuticals: Worthy Of A Position - seekingalpha.com

A Look At ANI Pharmaceuticals (ANIP) Valuation After Mixed Short Term Share Price Moves - Sahm

Why ANI Pharmaceuticals (ANIP) Stands Out as a Leading Long-Term Growth Stock - Bitget

Why ANI Pharmaceuticals (ANIP) is a Top Growth Stock for the Long-Term - finance.yahoo.com

ANI Pharmaceuticals, Inc. (ANIP) Stock forecasts - Yahoo Finance UK

ANI Pharmaceuticals, Inc. (ANIP) Stock Forecasts - Yahoo! Finance Canada

AGIO Rises on Mitapivat Progress Toward Accelerated Approval in SCD - TradingView

Is ANIP Undervalued? How to Read Its 9.3x Forward P/E - TradingView

ANI Pharmaceuticals 2026 Watchlist: Gout Sales Force and Rare Disease - finance.yahoo.com

Ultragenyx Pharmaceutical Announces FDA Acceptance of UX016 IND - TradingView

Volume Recap: Can ANI Pharmaceuticals Inc beat the S P 5002026 Spike Watch & Consistent Return Investment Signals - baoquankhu1.vn

SG Americas Securities LLC Buys 73,334 Shares of ANI Pharmaceuticals, Inc. $ANIP - MarketBeat

ANIP Stock Price, Quote & Chart | ANI PHARMACEUTICALS INC (NASDAQ:ANIP) - ChartMill

Price Action: Why is ANI Pharmaceuticals Inc stock going upWeekly Market Report & Daily Entry Point Trade Alerts - baoquankhu1.vn

RCKT Stock Down Despite FDA Nod to Gene Therapy in Rare Disease - TradingView

Assenagon Asset Management S.A. Has $7.09 Million Stock Position in ANI Pharmaceuticals, Inc. $ANIP - MarketBeat

ANI Pharma Insider Sells 4,772 Shares as Revenue Hits $883 Million in 2025 - AOL.com

ANI Pharma Insider Sells 4,772 Shares as Revenue Hits $883 Million in 2025 - The Motley Fool

Is Record 2025 Sales And 2026 Guidance Past US$1 Billion Altering The Investment Case For ANI Pharmaceuticals (ANIP)? - Sahm

Vanguard (ANIP) amendment: reports 0 shares after Jan 12, 2026 realignment - Stock Titan

How The ANI Pharmaceuticals (ANIP) Investment Narrative Is Shifting With Updated Analyst Assumptions - Yahoo Finance

IBRX Stock Slides on FDA Warning Over Misleading Cancer Drug Claims - TradingView

Risk Analysis: Will ANI Pharmaceuticals Inc announce a stock splitTrade Performance Summary & Weekly Breakout Opportunity Watchlist - baoquankhu1.vn

INSM Stock Gains After Arikayce Hits Goal in Label Expansion Study - TradingView

FDA Grants Priority Tag to Ionis' NDA for Alexander Disease Drug - TradingView

GSK's Risvutatug Rezetecan Gets Japan Orphan Drug Tag for Lung Cancer - TradingView

Oliver Luxxe Assets LLC Invests $1.82 Million in ANI Pharmaceuticals, Inc. $ANIP - MarketBeat

BioSante Pharmaceuticals and ANI Pharmaceuticals Announce Completion of Merger - Yahoo

ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Receives Consensus Recommendation of "Moderate Buy" from Brokerages - MarketBeat

ANI Pharmaceuticals Expands Ophthalmology Reach As Valuation Signals Upside Potential - Yahoo Finance

Assessing ANI Pharmaceuticals (ANIP) Valuation After Rare Disease Momentum And Alimera Acquisition - Sahm

Puma Biotechnology Stock Declines More Than 9% in a Month: Here's Why - TradingView

Agios Pharmaceuticals Stock Declines 23% in 6 Months: Here's Why - TradingView

Guggenheim Remains a Buy on ANI Pharmaceuticals (ANIP) - The Globe and Mail

ANIP Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI

Is ANI Pharmaceuticals (ANIP) Pullback Hiding A Contradiction In Its Valuation Story - simplywall.st

EPS Watch: Can ANI Pharmaceuticals Inc lead its sector in growthQuarterly Earnings Summary & Fast Entry Momentum Alerts - baoquankhu1.vn

COGT Rise as FDA Accepts Bezuclastinib NDA in Non-Advanced SM - tradingview.com

ANIP PE Ratio & Valuation, Is ANIP Overvalued - Intellectia AI

IBRX Stock Jumps on Progress in NK Cell Therapy Production - TradingView

Zacks Industry Outlook Features Terns Pharmaceuticals, ADMA Biologics, ANI Pharmaceuticals, and Liquidia - Bitget

Zacks Industry Outlook Highlights Terns Pharmaceuticals, ADMA Biologics, ANI Pharmaceuticals and Liquidia - The Globe and Mail

ANI Pharmaceuticals Insiders Unload $584K in Shares Amid 18-Month Selling Streak - AlphaStreet

234,219 Shares in ANI Pharmaceuticals, Inc. $ANIP Acquired by Divisadero Street Capital Management LP - MarketBeat

Apis Capital Advisors LLC Purchases 36,000 Shares of ANI Pharmaceuticals, Inc. $ANIP - MarketBeat

ANI Pharmaceuticals (NASDAQ:ANIP) Stock Rating Lowered by Wall Street Zen - MarketBeat

Ani Pharmaceuticals SVP Cook sells $36k in stock - Investing.com

Ani Pharmaceuticals SVP Cook sells $36k in stock By Investing.com - Investing.com South Africa

Meredith Cook Sells 500 Shares of ANI Pharmaceuticals (NASDAQ:ANIP) Stock - MarketBeat

Insider Selling: ANI Pharmaceuticals (NASDAQ:ANIP) Insider Sells 3,162 Shares of Stock - MarketBeat

Ani Pharmaceuticals Inc Azioni (ANIP) Dati Finanziari

Reddito

Reddito netto

Flusso di cassa

EPS

Simile a ANIP